High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, Rosíres Pereira de Andrade, Jorma Paavonen, O. L. E. E. Iversen, S‐E Olsson, John Høye, Margareta Steinwall, Grete Riis-Johannessen, Agneta Andersson‐Ellström, Kristina Elfgren, Geo von Krogh, Matti Lehtinen, C Malm, Gretchen Tamms, Katherine Giacoletti, Lisa Lupinacci, Radha Railkar, Frank J. Taddeo, Janine T. Bryan, Mark T. Esser, Heather L. Sings, Alfred J. Saah, Emily Barr

British Journal of Cancer, 2006

Instituto Paulo Gontijo, Ludwig Cancer Research, Instituto Brasileiro de Controle do Câncer, Universidade Estadual de Campinas (UNICAMP), University of Helsinki, Haukeland University Hospital, University of Bergen, Danderyds sjukhus, Karolinska Institutet, Drammen Hospital, Lund University, Malmö University, University of Gothenburg, Karolinska University Hospital, United States Military Academy

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with British Journal of Cancer. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

808

Citations

View on Google Scholar

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

Abstract

Journal Details

Join JournalsHub

Welcome Back